<DOC>
	<DOCNO>NCT00936299</DOCNO>
	<brief_summary>Attention deficit hyperactivity disorder ( ADHD ) one common co-occurring psychiatric disorder ( 30-50 % ) adolescent substance use disorder ( SUD ) . Yet , little known safety efficacy medication ADHD adolescent SUD , since youth exclude medication trial . Clinicians therefore understandably reluctant treat ADHD substance abuse adolescent , often first refer youths substance treatment . Untreated ADHD associate poor substance treatment outcomes . We address research gap propose randomize controlled trial bupropion v placebo 130 adolescent ( 13-19 year ) Diagnostic Statistical Manual ( DSM IV ) ADHD , nicotine dependence cannabis use disorder ( exclude SUD ) . Participants bupropion placebo treatment group receive weekly individual manualized-standardized cognitive behavioral therapy ( CBT ) target SUD ( cost ) throughout 16 week medication trial . Bupropion also effective treat nicotine dependence adult ; majority adolescent marijuana drug abuse also smoke tobacco . More recent research adult indicate bupropion may reduce crave use substance abuse ( e.g . methamphetamine , cocaine ) . It 's possible impact cannabis use disorder ( addiction teen refer treatment ) yet evaluate . However since drug abuse final common pathway leading addiction via action call brain reward system ( ventral tegmental area ( VTA ) , accumbens ) -an important secondary aim evaluate bupropion 's potential impact crave use marijuana ( MJ ) addition know similar action nicotine .</brief_summary>
	<brief_title>Bupropion ADHD Adolescents With Substance Use Disorder</brief_title>
	<detailed_description>Research show bupropion safe effective treatment ADHD nicotine dependence individual without SUD , new research provide empirical support unique pharmacotherapeutic property potential treat addictive disorder ( e.g. , methamphetamine dependence , pathological gambling ) . No controlled study yet evaluate bupropion 's safety efficacy ADHD SUD ( include nicotine cannabis ) adolescent . The lack research safety efficacy medication adolescent SUD psychiatric comorbidities contribute serious lack integrated treatment commonly co-occurring mental health substance problem community-based adolescent drug treatment program . This contribute poor treatment outcome prognosis large number comorbid youth substance abuse mental health problem significantly impact public health . The specific aim propose study address research gap conduct 16-week randomize control trial bupropion vs. placebo evaluate safety efficacy low abuse potential medication ADHD , nicotine dependence , cannabis use disorder ( exclude SUD ) 130 adolescent ( 13-19 ) receive concurrent outpatient substance treatment ( CBT ) . The study design analytic approach enable assessment complex inter-relationship change ADHD , depression/dysphoria ( psychiatric symptom ) change nicotine , cannabis substance use within treatment group . Thus , study address important research gap least two priority area National Institute Drug Abuse/ National Institutes Health ( NIDA/NIH ) research agenda : 1 ) research effective treatment adolescent addiction psychiatric comorbidity , 2 ) medication development research nicotine cannabis use disorder adolescent .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>Subjects must 1 ) age 13 19 , parent legal guardian available complete parental assessment minor ; 2 ) meet DSMIV diagnostic criterion ADHD KSADSPL ; 3 ) Schedule Affective Disorders Schizophrenia score = &gt; 22 DSMIV ADHD symptom checklist ; 4 ) meet DSMIV criterion nicotine dependence ( and/or cut score &gt; 3 modify Fagerstrom ) ; 5 ) meet DSMIV criterion cannabis abuse dependence KiddieSadsPresent Lifetime ( KSADSPL ) ; 6 ) use marijuana least 5 past 30 day ; 7 ) use nicotine least 15 day past 30 day ; 8 ) medically healthy ; 9 ) use effective birth control method female sexually active . Subjects follow excluded:1 ) current past psychosis ; 2 ) bipolar I II disorder ; 3 ) firstdegree relative bipolar I disorder ; 4 ) lifetime history seizure disorder ; 5 ) chronic serious medical illness ; 6 ) lifetime history eat disorder ; 7 ) current pregnancy ; 8 ) previous clinically significant adverse reaction bupropion ; 9 ) need take psychotropic medication time study entry . Patients may previous psychotherapy pharmacotherapy ADHD comorbidity psychotropic medication least one month prior study entry ; 10 ) active participation substance abuse treatment mental health treatment ( include outpatient , daytreatment , residential , inpatient ) within 28 day prior sign consent ; 11 ) nonEnglish speaking ( due difficulty translate additional material give subject ) ; 12 ) cognitively impaired low intelligence ; 13 ) breastfeeding ; 14 ) current use psychotropic medication include nicotine replacement therapy ; 15 ) current opiate dependence .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>19 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Adolescents</keyword>
	<keyword>Substance Use Disorder</keyword>
	<keyword>Attention Deficit Hyperactivity Disorder</keyword>
	<keyword>Cognitive Behavioral Therapy</keyword>
</DOC>